Cases 21 - 30 of 111
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al
as 1:2021cv00530
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al
as 1:2021cv00356
Defendant:
Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited,
Plaintiff:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMA INC.
as 2:2021cv00564
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
Qila Pharma Inc. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMACEUTICAL CO., LTD. et al
as 3:2021cv01732
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
QILU PHARMACEUTICAL CO., LTD. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited et al
as 1:2020cv01585
Defendant:
Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited
Plaintiff:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al
as 1:2020cv01153
Defendant:
Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc. and Sun Pharmaceutical Industries Limited,
Plaintiff:
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 2:2020cv02545
Plaintiff:
BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Defendant:
HEC PHARM USA and HEC PHARM CO., LTD.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00277
Defendant:
Annora Pharma Private Limited and Hetero USA Inc.,
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd.
as 5:2020cv00023
Plaintiff:
Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and others
Defendant:
Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
